We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Gastroenterology

Journal Scan / Research · September 09, 2021

Microbial Determinants Impact Responses to Biologic Therapies in Inflammatory Bowel Disease

Cell Host & Microbe

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cell Host & Microbe
Multi-Omics Reveal Microbial Determinants Impacting Responses to Biologic Therapies in Inflammatory Bowel Disease
Cell Host Microbe 2021 Aug 11;29(8)1294-1304.e4, JWJ Lee, D Plichta, L Hogstrom, NZ Borren, H Lau, SM Gregory, W Tan, H Khalili, C Clish, H Vlamakis, RJ Xavier, AN Ananthakrishnan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading